Jade Biosciences (JBIO) Non-cash Items (2021 - 2026)

Jade Biosciences has reported Non-cash Items for 6 years, with the latest figure at $78823.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items fell 71.95% year-over-year to $78823.0; the trailing twelve-month figure through Mar 2026 stood at $78823.0 (down 71.95% YoY), and the FY2025 full-year result was $92693.0, up 743.2% from the prior year.
• Non-cash Items for Q1 2026 stood at $78823.0, down from $92693.0 in the prior quarter.
• The five-year high for Non-cash Items was $93.5 million in Q1 2024, with the low at $10993.0 in Q4 2024.
• Historically, Non-cash Items has averaged $30.9 million across 5 years, with a median of $30.8 million in 2022.
• Annual changes were most pronounced in 2024 — Non-cash Items plunged 99.98% — and 2025, when it soared 244108.33%.
• Jade Biosciences' Non-cash Items stood at $82.5 million in 2022, then slumped by 39.72% to $49.7 million in 2023, then slumped by 99.98% to $10993.0 in 2024, then surged by 743.2% to $92693.0 in 2025, then dropped by 14.96% to $78823.0 in 2026.
• The last three Non-cash Items figures came in at $78823.0 (Q1 2026), $92693.0 (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.